Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox-related mechanisms
- PMID: 28904402
- PMCID: PMC5597619
- DOI: 10.1038/s41598-017-11869-8
Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox-related mechanisms
Abstract
In accordance with the classification of the International Agency for Research on Cancer, extremely low frequency magnetic fields (ELF-MF) are suspected to promote malignant progression by providing survival advantage to cancer cells through the activation of critical cytoprotective pathways. Among these, the major antioxidative and detoxification defence systems might be targeted by ELF-MF by conferring cells significant resistance against clinically-relevant cytotoxic agents. We investigated whether the hyperproliferation that is induced in SH-SY5Y human neuroblastoma cells by a 50 Hz, 1 mT ELF magnetic field was supported by improved defence towards reactive oxygen species (ROS) and xenobiotics, as well as by reduced vulnerability against both H2O2 and anti-tumor ROS-generating drug doxorubicin. ELF-MF induced a proliferative and survival advantage by activating key redox-responsive antioxidative and detoxification cytoprotective pathways that are associated with a more aggressive behavior of neuroblastoma cells. This was coupled with the upregulation of the major sirtuins, as well as with increased signaling activity of the erythroid 2-related nuclear transcription factor 2 (NRF2). Interestingly, we also showed that the exposure to 50 Hz MF as low as 100 µT may still be able to alter behavior and responses of cancer cells to clinically-relevant drugs.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monogr. Eval. Carcinog. Risks Hum. 80, 1–395 (2002). - PubMed
-
- Poulletier de Gannes, F., Lagroye, I. & Veyret, B. D3 - Report on the analysis of risks associated to exposure to EMF: in vitro and in vivo (animals) studies. European Health Risk Assessment Network on Electromagnetic Fields Exposure (EFHRAN). Available at http://efhran.polimi.it/docs/IMS-EFHRAN_09072010.pdf (2010).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
